Literature DB >> 1895305

N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.

R D Thompson1, S Secunda, J W Daly, R A Olsson.   

Abstract

N6-Substituted 9-methyladenines are potent antagonists of the activation of A1 adenosine receptors. The present study assessed the effect of N6 and N-9 substituents on the binding of adenines to the A1 and A2 receptors, respectively, of rat brain cortex and striatum and also on the antagonism of the A2 receptor mediated stimulation of the adenylate cyclase of PC12 cells by N-ethyladenosine-5'-uronamide. The potency ranking of 9-substituted adenines varied directly with the hydrophobicity of the substituent: cyclopentyl greater than phenyl greater than tetrahydrofuryl greater than ethyl greater than methyl greater than 2-hydroxyethyl. The 9-substituted adenines showed little selectivity for either receptor and the R enantiomer of N6-(1-phenyl-2-propyl)-9-methyladenine was only 4-fold more potent than the S enantiomer at the A1 receptor. An N6-cyclopentyl substituent increased potency at the A1 receptor and decreased potency at the A2 receptor, resulting in selectivity for the A1 receptor of up to 39-fold. The N6-cyclopentyl group completely overshadowed the effect of the hydrophobicity of the 9-substituent. A 2-chloro substituent did not alter the potency of an N6-substituted 9-methyladenine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895305     DOI: 10.1021/jm00113a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  A binding site model and structure-activity relationships for the rat A3 adenosine receptor.

Authors:  P J van Galen; A H van Bergen; C Gallo-Rodriguez; N Melman; M E Olah; A P IJzerman; G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

2.  "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.

Authors:  Melissa Perreira; Jian-Kang Jiang; Athena M Klutz; Zhan-Guo Gao; Asher Shainberg; Changrui Lu; Craig J Thomas; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

3.  9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities.

Authors:  Karl-Norbert Klotz; Sonja Kachler; Catia Lambertucci; Sauro Vittori; Rosaria Volpini; Gloria Cristalli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-07       Impact factor: 3.000

Review 4.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

Review 5.  John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Silvia Paoletta; Evgeny Kiselev; Saibal Chakraborty; P Suresh Jayasekara; Ramachandran Balasubramanian; Dilip K Tosh
Journal:  Comput Struct Biotechnol J       Date:  2014-10-16       Impact factor: 7.271

6.  Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates.

Authors:  Rao V Kalla; Jeff Zablocki
Journal:  Purinergic Signal       Date:  2008-06-21       Impact factor: 3.765

7.  Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.

Authors:  S M Siddiqi; K A Jacobson; J L Esker; M E Olah; X D Ji; N Melman; K N Tiwari; J A Secrist; S W Schneller; G Cristalli
Journal:  J Med Chem       Date:  1995-03-31       Impact factor: 7.446

8.  Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.

Authors:  K A Jacobson; S M Siddiqi; M E Olah; X D Ji; N Melman; K Bellamkonda; Y Meshulam; G L Stiles; H O Kim
Journal:  J Med Chem       Date:  1995-05-12       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.